Lys-[Des-Arg9]-Bradykinin is a bradykinin analog lacking the C-terminal arginine while carrying an N-terminal lysine extension. Structural modifications modulate receptor subtype selectivity and signaling bias. Researchers use it to dissect kinin receptor pharmacology and binding-site topology. The peptide supports fine mapping of contact residues in kinin pathways.
CAT No: B09001
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More